Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 13, 2010Endocrine Related CancerOpen Access

Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ELElizabeth W. LaPenseeUniversity of MichiganNBNira Ben‐JonathanUniversity of Cincinnati

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

LaPensee et al. (2010) studied this question.

synapsesocial.com/papers/6a88747e8e586ad1c8a55b59https://doi.org/10.1677/erc-09-0253
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent2001 · 311 citations
  2. 2Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity2008 · 62 citations
  3. 3Prolactin acts as a potent survival factor for human breast cancer cell lines2004 · 114 citations